Working… Menu

A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03460990
Recruitment Status : Completed
First Posted : March 9, 2018
Last Update Posted : December 4, 2018
Information provided by (Responsible Party):
Vertex Pharmaceuticals Incorporated

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 26, 2018
Actual Study Completion Date : October 8, 2018